Table 3.

Radiotherapy treatment.

Patients randomised	carboplatin + paclitaxel		cisplatin + capecitabine
	31		32
	n	%	n	%
Planned dose
50Gy	17	54.8	14	43.8
60Gy	14	45.2	18	56.3
Planned 50Gy∗
Given 50Gy in 25#	15	88.2	12	85.7
Other dose given	2a	11.8	1b	7.1
No RT given	0	0.0	1	7.1∗∗
Planned 60Gy∗
Given 60Gy in 25#	10	71.4	16	88.9
Other dose given	4c	28.6	2d	11.1
No RT given	0	0.0	0	0.0
Days from randomisation to start of RT – median (IQR)	26 (25–32)		26 (24–27)
Delays during RT
Yes	3	9.7	5	15.6
No	28	90.3	26	81.3
N/A – no RT given	0	0.0	1	3.1
Median delay in days (IQR)	8 (1–33)		4 (1–7)
Reasons for delay
Toxicity	0	0.0	3	9.4
Patient choice	1	3.2	0	0.0
Stent/replan/other treatment	2	6.5	1	3.1
Bank holiday	0	0.0	1	3.1

Denominator for % is randomized patients except for ∗ where denominator is number of patients with this planned dose ∗∗withdrew from treatment after cycle 1 due to disease progression.

^a48Gy in 24# due to toxicity; 50Gy in 5# and 40gy in 20#.

^b36Gy in 18#.

^c50Gy in 25#; 51Gy in 27#; 50Gy in 25#; 60Gy in 5# and 48Gy in 20#.

^d24Gy in 12#; 60Gy in 1# and 57.6Gy in 3# and 42Gy in 21#.